The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Cardiovascular manifestations of phaeochromocytoma
Abstract
Clinical expression of phaeochromocytoma may involve numerous cardiovascular manifestations, but usually presents as sustained or paroxysmal hypertension associated with other signs and symptoms of catecholamine excess. Most of the life-threatening cardiovascular manifestations of phaeochromocytoma, such as hypertensive emergencies, result from a rapid and massive release of catecholamines from the tumour. More rarely, patients with phaeochromocytoma present with low blood pressure or even shock that may then precede multisystem crisis. Sinus tachycardia, with palpitations as the presenting symptom, is the most prevalent abnormality of cardiac rhythm in phaeochromocytoma, but tumours can also be associated with more serious ventricular arrhythmias or conduction disturbances. Reversible dilated or hypertrophic cardiomyopathy are well established cardiac manifestations of phaeochromocytoma, with more recent attention to an increasing number of cases with Takotsubo cardiomyopathy. This review provides an update on the cause, clinical presentation and treatment of the cardiovascular manifestations of phaeochromocytoma. As the cardiovascular complications of phaeochromocytoma can be life-threatening, all patients who present with manifestations that even remotely suggest excessive catecholamine secretion should be screened for the disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lenders, J. W., Eisenhofer, G., Mannelli, M., & Pacak, K. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67139-5 · Cited by 1,524
Self-citationApical ballooning syndrome or takotsubo cardiomyopathy: a systematic review
Gianni, M., Dentali, F., Grandi, A. M., Sumner, G., Hiralal, R., & Lonn, E. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl032 · Cited by 1,510
SDHA is a tumor suppressor gene causing paraganglioma
Burnichon, N., Brière, J.-J., Libé, R., Vescovo, L., Rivière, J., Tissier, F., Jouanno, E., Jeunemaitre, X., Bénit, P., Tzagoloff, A., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq206 · Cited by 650
Baroreflex Control of Sympathetic Nerve Activity in Essential and Secondary Hypertension
Grassi, G., Cattaneo, B. M., Seravalle, G., Lanfranchi, A., & Mancia, G. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.68 · Cited by 526
Focal Myocarditis Associated with Pheochromocytoma
Van Vliet, P. D., Burchell, H. B., & Titus, J. L. (1966) · New England Journal of Medicine · doi:10.1056/nejm196605192742002 · Cited by 428
Amar, L., Servais, A., Gimenez-Roqueplo, A.-P., Zinzindohoue, F., Chatellier, G., & Plouin, P.-F. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1398 · Cited by 390
Galiuto, L., De Caterina, A. R., Porfidia, A., Paraggio, L., Barchetta, S., Locorotondo, G., Rebuzzi, A. G., & Crea, F. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq039 · Cited by 322
Pheochromocytoma: presentation, diagnosis and treatment
Reisch, N., Peczkowska, M., Januszewicz, A., & Neumann, H. P. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000251887.01885.54 · Cited by 263
Self-citationRisk Factors for Hemodynamic Instability during Surgery for Pheochromocytoma
Bruynzeel, H., Feelders, R. A., Groenland, T. H. N., van den Meiracker, A. H., van Eijck, C. H. J., Lange, J. F., de Herder, W. W., & Kazemier, G. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1051 · Cited by 245
Vascular Hypertrophy and Remodeling in Secondary Hypertension
Rizzoni, D., Porteri, E., Castellano, M., Bettoni, G., Muiesan, M. L., Muiesan, P., Giulini, S. M., & Agabiti-Rosei, E. (1996) · Hypertension · doi:10.1161/01.hyp.28.5.785 · Cited by 238
Plouin, P.-F., Duclos, J.-M., Soppelsa, F., Boublil, G., & Chatellier, G. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.4.7392 · Cited by 201
Reversibility of Catecholamine-Induced Dilated Cardiomyopathy in a Child with a Pheochromocytoma
Imperato-McGinley, J., Gautier, T., Ehlers, K., Zullo, M. A., Goldstein, D. S., & Vaughan, E. D. (1987) · New England Journal of Medicine · doi:10.1056/nejm198703263161307 · Cited by 198
Adameova, A., Abdellatif, Y., & Dhalla, N. S. (2009) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y09-042 · Cited by 184
Efficacy and Safety of Doxazosin for Perioperative Management of Patients with Pheochromocytoma
Prys‐Roberts, C., & Farndon, J. R. (2002) · World Journal of Surgery · doi:10.1007/s00268-002-6667-z · Cited by 182
Adverse Drug Reactions in Patients with Phaeochromocytoma: Incidence, Prevention and Management
Eisenhofer, G., Rivers, G., Rosas, A. L., Quezado, Z., Manger, W. M., & Pacák, K. (2007) · Drug Safety · doi:10.2165/00002018-200730110-00004 · Cited by 158
Self-citationPlouin, P. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.4.1480 · Cited by 146
Pheochromocytoma: effect of nonionic contrast medium in CT on circulating catecholamine levels.
Mukherjee, J. J., Peppercorn, P. D., Reznek, R. H., Patel, V., Kaltsas, G., Besser, M., & Grossman, A. B. (1997) · Radiology · doi:10.1148/radiology.202.1.8988215 · Cited by 130
Bessell-Browne, R., & O'Malley, M. E. (2007) · American Journal of Roentgenology · doi:10.2214/ajr.06.0827 · Cited by 127
Endothelial Dysfunction in Hypertension Is Independent From the Etiology and From Vascular Structure
Rizzoni, D., Porteri, E., Castellano, M., Bettoni, G., Muiesan, M. L., Tiberio, G. A. M., Giulini, S. M., Rossi, G. P., Bernini, G., & Agabiti‐Rosei, E. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.335 · Cited by 116
Takizawa, M., Kobayakawa, N., Uozumi, H., Yonemura, S., Kodama, T., Fukusima, K., Takeuchi, H., Kaneko, Y., Kaneko, T., Fujita, K., et al. (2006) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.07.125 · Cited by 114
Pheochromocytoma Multisystem Crisis
Newell, K. A. (1988) · Archives of Surgery · doi:10.1001/archsurg.1988.01400320042007 · Cited by 109
The Protean Manifestations of Pheochromocytoma
Manger, W. M. (2009) · Hormone and Metabolic Research · doi:10.1055/s-0028-1128139 · Cited by 108
Alpha blockade in preoperative preparation of patients with pheochromocytomas.
Koçak, S., Aydıntuğ, S., & Çanakçi, N. (2002) · PubMed · Cited by 103
Pheochromocytoma as an Endocrine Emergency
Brouwers, F. M., Lenders, J. W. M., Eisenhofer, G., & Pacák, K. (2003) · Reviews in Endocrine and Metabolic Disorders · doi:10.1023/a:1022981801344 · Cited by 100
Self-citationRosas, A. L., Kasperlik-Zaluska, A. A., Papierska, L., Bass, B. L., Pacák, K., & Eisenhofer, G. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0778 · Cited by 100
Self-citationMechanisms of orthostatic hypotension and tachycardia in patients with pheochromocytoma
Streeten, D. H. P. (1996) · American Journal of Hypertension · doi:10.1016/0895-7061(96)00057-x · Cited by 90
Emergencies Caused by Pheochromocytoma, Neuroblastoma, or Ganglioneuroma
Brouwers, F. M., Eisenhofer, G., Lenders, J. W. M., & Pacák, K. (2006) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2006.09.014 · Cited by 80
Self-citationClinically Unsuspected Pheochromocytomas
Krane, N. K. (1986) · Archives of Internal Medicine · doi:10.1001/archinte.1986.00360130064008 · Cited by 79
Jebara, V. A., Sousa‐Uva, M., Farge, A., et al. (1992) · The Annals of Thoracic Surgery · doi:10.1016/0003-4975(92)91354-c · Cited by 75
Noncardiogenic pulmonary edema as the sole manifestation of pheochromocytoma.
de Leeuw, P. W., Waltman, F. L., & Birkenhäger, W. H. (1986) · Hypertension · doi:10.1161/01.hyp.8.9.810 · Cited by 70
Baid, S. K., Lai, E. W., Wesley, R. A., Ling, A., Timmers, H. J. L. M., Adams, K. T., Kozupa, A., & Pacak, K. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-1-200901060-00006 · Cited by 66
Kang, J. M., Lee, W. J., Kim, W. B., Kim, T. Y., Koh, J., Hong, S. J., Huh, J., Ro, J. Y., Chi, H. S., & Kim, M. (2005) · Endocrine Journal · doi:10.1507/endocrj.52.193 · Cited by 62
Blood pressure regulation in pheochromocytoma
BRAVO, E. L., Tarazi, R. C., Fouad, F. M., Textor, S. C., Gifford, R. W., & Vidt, D. G. (1982) · Hypertension · doi:10.1161/01.hyp.4.3_pt_2.193 · Cited by 61
Increased blood pressure variability in pheochromocytoma compared to essential hypertension patients
Zelinka, T., Štrauch, B., Petrák, O., Holaj, R., Vranková, A., Weisserová, H., Pacák, K., & Widimsky, J., Jr. (2005) · Journal of Hypertension · doi:10.1097/01.hjh.0000185714.60788.52 · Cited by 58
Diurnal blood pressure variationin pheochromocytoma, primary aldosteronism and Cushing's syndrome
Zelinka, T., Štrauch, B., Pecen, L., & Widimsky, J., Jr. (2004) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001644 · Cited by 55
Phaeochromocytoma and acute cardiovascular death (with special reference to myocardial infarction)
Cohen, C. D., & DENT, D. M. (1984) · Postgraduate Medical Journal · doi:10.1136/pgmj.60.700.111 · Cited by 54
A reevaluation of the hemodynamics of pheochromocytoma.
Bravo, E., Fouad-Tarazi, F. M., Rossi, G. P., Imamura, M., Lin, W. W., Madkour, M. A., Wicker, P., Cressman, M. D., & Saragoça, M. A. (1990) · Hypertension · doi:10.1161/01.hyp.15.2_suppl.i128 · Cited by 50
Brown, H. A., Goldberg, P. A., Selter, J. G., Cabin, H. S., Marieb, N. J., Udelsman, R., & Setaro, J. F. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1077 · Cited by 48
Bravo, E. L. (2002) · Cardiology in Review · doi:10.1097/00045415-200201000-00009 · Cited by 48
Phaeochromocytomas as a cause of hypotension
Baxter, M. A., Hunter, P., Thompson, G. R., & London, D. R. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb02326.x · Cited by 44
QT prolongation with torsade de pointes in pheochromocytoma
Shimizu, K., Miura, Y., Meguro, Y., Noshiro, T., Ohzeki, T., Kusakari, T., Akama, H., Watanabe, T., Honma, H., Imai, Y., et al. (1992) · American Heart Journal · doi:10.1016/0002-8703(92)90954-t · Cited by 42
Intrapericardial pheochromocytoma
Saad, M. F., Frazier, O. H., Hickey, R. C., et al. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)91220-2 · Cited by 42
Munakata, M. (1999) · American Journal of Hypertension · doi:10.1016/s0895-7061(99)00026-6 · Cited by 40
Adrenergic mechanisms and remodeling of subcutaneous small resistance arteries in humans
Porteri, E., Rizzoni, D., Mulvany, M. J., Ciuceis, C. D., Sleiman, I., Boari, G. E. M., Castellano, M., Muiesan, M. L., Zani, F., & Rosei, E. A. (2003) · Journal of Hypertension · doi:10.1097/00004872-200312000-00024 · Cited by 40
Elian, D., Harpaz, D., Sucher, E., Kaplinsky, E., Motro, M., & Vered, Z. (2008) · Cardiology · doi:10.1159/000175956 · Cited by 37
Circadian Blood Pressure Variations in Endocrine Disorders
Spieker, C., Barenbrock, M., Rahn, K. H., & Zidek, W. (1993) · Blood Pressure · doi:10.3109/08037059309077524 · Cited by 33
Pheochromocytoma associated ventricular tachycardia blocked with atenolol
Michaels, R. D., Hays, J. H., O’Brian, J. T., & Shakir, K. M. M. (1990) · Journal of Endocrinological Investigation · doi:10.1007/bf03349666 · Cited by 32
Cardiac pheochromocytoma involving the left main coronary artery presenting with exertional angina
Stowers, S. A., Gilmore, P. S., Stirling, M. C., et al. (1987) · American Heart Journal · doi:10.1016/0002-8703(87)90513-8 · Cited by 24
Myocardial infarction resulting from nonatherosclerotic coronary artery diseases
Mirza, A. (2003) · The American Journal of Emergency Medicine · doi:10.1016/s0735-6757(03)00104-9 · Cited by 23
Phaeochromocytoma in Northern Ireland: a 21 year review.
Beatty, O. L., Russell, C. F. J., Kennedy, L., et al. (1996) · PubMed · Cited by 22
Characteristics of Blood Pressure in Pheochromocytoma
Zelinka, T., Pacák, K., & Widimsky, J., Jr. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1353.009 · Cited by 21
Zangrillo, A., Valentini, G., Casati, A., & Torri, G. (1999) · European Journal of Anaesthesiology · doi:10.1046/j.1365-2346.1999.00474.x · Cited by 21
Dabrowska, B., Pruszczyk, P., Dâbrowski, A., Feltynowski, T., Wocial, B., & Januszewicz, W. (1995) · PubMed · Cited by 19
Evaluation of orthostatic hypotension using power spectral analysis.
Moriguchi, A., Otsuka, A., Kohara, K., et al. (1993) · PubMed · Cited by 18
Kintscher, U. (2009) · Journal of Hypertension · doi:10.1097/01.hjh.0000354519.67451.96 · Cited by 17
Pheochromocytoma and Myocardial Infarction
Garg, A., & Banitt, P. F. (2004) · Southern Medical Journal · doi:10.1097/01.smj.0000141310.27872.84 · Cited by 16
Torsades de Pointes: A Rare Complication of an Extra-Adrenal Pheochromocytoma
Methe, H., Hinterseer, M., Wilbert-Lampen, U., Beckmann, B. M., Steinbeck, G., & Kääb, S. (2007) · Hypertension Research · doi:10.1291/hypres.30.1263 · Cited by 16
Goswami, R., Tandon, N., Singh, B. B., & Kochupillai, N. (1995) · International Journal of Cardiology · doi:10.1016/0167-5273(95)02302-d · Cited by 14
Risks of hemodynamic instability in pheochromocytoma
Eisenhofer, G., & Bornstein, S. R. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.65 · Cited by 12
Self-citationPhaeochromocytoma with adult respiratory distress syndrome mimicking septicaemic shock
Mok, C., Ip, T., & So, C. C. (1997) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1997.tb123298.x · Cited by 11
Takabatake, T., Yamamoto, Y., Ohta, H., Nakamura, S., Hara, H., Ishida, Y.-I., Hashimoto, N., & Hattori, N. (1985) · Clinical and Experimental Hypertension · doi:10.3109/10641968509073543 · Cited by 9
ECG abnormalities of endocrine origin
Donckier, J. E., DELGRANGE, E., & MICHEL, L. (2001) · Heart · doi:10.1136/heart.85.6.679 · Cited by 4
Percutaneous aortic valve replacement with the CoreValve bioprosthesis
Zegdi, R., Achouh, P., & Fabiani, J. (2008) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2007.11.054 · Cited by 3
Cited by
Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline
Lenders, J. W. M., Duh, Q.-Y., Eisenhofer, G., Gimenez-Roqueplo, A.-P., Grebe, S. K. G., Murad, M. H., Naruse, M., Pacak, K., & Young, W. F. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1498 · Cited by 2,827
Self-citationThe Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)
Umemura, S., Arima, H., Arima, S., Asayama, K., Dohi, Y., Hirooka, Y., Horio, T., Hoshide, S., Ikeda, S., Ishimitsu, T., et al. (2019) · Hypertension Research · doi:10.1038/s41440-019-0284-9 · Cited by 1,880
Lenders, J. W. M., Kerstens, M. N., Amar, L., Prejbisz, A., Robledo, M., Taieb, D., Pacak, K., Crona, J., Zelinka, T., Mannelli, M., et al. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002438 · Cited by 413
Self-citationGorenek, B., Boriani, G., Dan, G.-A., Fauchier, L., Fenelon, G., Huang, H., Kudaiberdieva, G., Lip, G. Y. H., Mahajan, R., Potpara, T., et al. (2018) · EP Europace · doi:10.1093/europace/euy051 · Cited by 43
Metadata
- Authors
- Prejbisz, A., Lenders, J. W. M., Eisenhofer, G., & Januszewicz, A.
- Venue
- Journal of Hypertension
- Published
- 2011-11
- Volume
- 29
- Issue
- 11
- Pages
- 2049-2060
- ISSN
- 0263-6352 (ISSN-L)
- OpenAlex
- W2066365902
- Cited by
- 291
- References
- 63
- FWCI
- 15.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.